ITMI921556A0 - Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani - Google Patents
Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadianiInfo
- Publication number
- ITMI921556A0 ITMI921556A0 IT92MI1556A ITMI921556A ITMI921556A0 IT MI921556 A0 ITMI921556 A0 IT MI921556A0 IT 92MI1556 A IT92MI1556 A IT 92MI1556A IT MI921556 A ITMI921556 A IT MI921556A IT MI921556 A0 ITMI921556 A0 IT MI921556A0
- Authority
- IT
- Italy
- Prior art keywords
- agonists
- interfere
- diseases
- particularly effective
- drug containing
- Prior art date
Links
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 230000002060 circadian Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
- 229960003987 melatonin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI921556A IT1254995B (it) | 1992-06-24 | 1992-06-24 | Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani |
JP5152525A JPH0672874A (ja) | 1992-06-24 | 1993-06-24 | 概日リズム障害疾患用薬剤 |
EP93830270A EP0578620B1 (en) | 1992-06-24 | 1993-06-24 | Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues |
DE69330150T DE69330150D1 (de) | 1992-06-24 | 1993-06-24 | Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge |
AT93830270T ATE200617T1 (de) | 1992-06-24 | 1993-06-24 | Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge |
US08/196,380 US5552428A (en) | 1992-06-24 | 1994-02-15 | Compounds effective in the treatment of circadian rhythms and related disorders, the novel pharmaceutical preparations and novel method of application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI921556A IT1254995B (it) | 1992-06-24 | 1992-06-24 | Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI921556A0 true ITMI921556A0 (it) | 1992-06-24 |
ITMI921556A1 ITMI921556A1 (it) | 1993-12-24 |
IT1254995B IT1254995B (it) | 1995-10-11 |
Family
ID=11363575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI921556A IT1254995B (it) | 1992-06-24 | 1992-06-24 | Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0578620B1 (it) |
JP (1) | JPH0672874A (it) |
AT (1) | ATE200617T1 (it) |
DE (1) | DE69330150D1 (it) |
IT (1) | IT1254995B (it) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591768A (en) * | 1990-12-04 | 1997-01-07 | State Of Oregan, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | Methods for treating circadian rhythm phase disturbances |
US6638963B1 (en) | 1990-12-04 | 2003-10-28 | Oregon Health And Science University | Methods for treating circadian rhythm disorders |
US5449683A (en) * | 1992-10-01 | 1995-09-12 | Massachussetts Institute Of Technology | Methods of inducing sleep using melatonin |
US5654325A (en) * | 1993-11-18 | 1997-08-05 | Eli Lilly And Company | Melatonin derivatives for use in treating sleep disorders |
US6180657B1 (en) * | 1993-11-18 | 2001-01-30 | Eli Lilly And Company | Melatonin derivatives for use in treating desynchronization disorders |
CA2182700A1 (en) * | 1994-03-30 | 1995-10-12 | Irmgard Wiesenberg | Screening method using the rzr receptor family |
DE19713141A1 (de) * | 1996-03-29 | 1997-10-30 | Labtec Gmbh | Transdermales System mit Melatonin |
FR2754454B1 (fr) * | 1996-10-10 | 1998-11-27 | Oreal | Utilisation d'au moins un glycol comme agent de solubilisation de la melatonine dans l'eau et compositions obtenues |
IT1289939B1 (it) * | 1997-02-20 | 1998-10-19 | Angelini Ricerche Spa | Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua |
EP1214944B1 (en) | 1999-08-20 | 2009-09-23 | Takeda Pharmaceutical Company Limited | Composition for PERCUTANEOUS ABSORPTION with a compound having a melatonin receptor agonist activity |
CA2381860C (en) | 1999-08-26 | 2009-11-24 | Takeda Chemical Industries, Ltd. | Matrix adhering to nasal mucosa |
US7884037B2 (en) | 2006-12-15 | 2011-02-08 | Kimberly-Clark Worldwide, Inc. | Wet wipe having a stratified wetting composition therein and process for preparing same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6045513A (ja) * | 1983-05-18 | 1985-03-12 | モナシユ ユニバ−シテイ | 身体行動および機能の日周期の不調を軽減する薬剤 |
ATE77230T1 (de) * | 1985-03-04 | 1992-07-15 | Cell Eng Ag | Melatoninhaltige mittel sowie deren verwendungen. |
JPS61212512A (ja) * | 1985-03-19 | 1986-09-20 | Shiseido Co Ltd | 養毛料 |
JPS61221106A (ja) * | 1985-03-28 | 1986-10-01 | Shiseido Co Ltd | 皮膚外用剤 |
GB8517958D0 (en) * | 1985-07-16 | 1985-08-21 | Cellena Cell Eng Ag | Compositions containing melatonin/homologues |
JPH0418034A (ja) * | 1990-05-11 | 1992-01-22 | Kanegafuchi Chem Ind Co Ltd | 点眼組成物 |
EP0483077B1 (en) * | 1990-09-28 | 1995-12-06 | I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi | A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas. |
EP0518468B1 (en) * | 1991-05-09 | 1999-06-30 | Neurim Pharmaceuticals (1991) Limited | Melatonin containing compositions |
IT1251544B (it) * | 1991-05-13 | 1995-05-17 | Gabriele Biella | Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico |
US5508039A (en) * | 1991-10-18 | 1996-04-16 | Alza Corporation | Controlled transdermal administration of melatonin |
-
1992
- 1992-06-24 IT ITMI921556A patent/IT1254995B/it active IP Right Grant
-
1993
- 1993-06-24 AT AT93830270T patent/ATE200617T1/de not_active IP Right Cessation
- 1993-06-24 JP JP5152525A patent/JPH0672874A/ja active Pending
- 1993-06-24 EP EP93830270A patent/EP0578620B1/en not_active Expired - Lifetime
- 1993-06-24 DE DE69330150T patent/DE69330150D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IT1254995B (it) | 1995-10-11 |
EP0578620A1 (en) | 1994-01-12 |
DE69330150D1 (de) | 2001-05-23 |
EP0578620B1 (en) | 2001-04-18 |
ATE200617T1 (de) | 2001-05-15 |
JPH0672874A (ja) | 1994-03-15 |
ITMI921556A1 (it) | 1993-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO305886B1 (no) | Anvendelse av et organisk nitritt for fremstilling av medikamenter for kontinuerlig, vasodilatorisk terapi | |
DE3688710D1 (de) | Isolierung und pharmazeutische verwendung von hyaluronidase und diese enthaltende pharmazeutische und tieraerztliche praeparate. | |
IT1199760B (it) | Dispositivo terapeutico per la somministrazione di medicamenti | |
DK0513702T3 (da) | Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering | |
ZA928011B (en) | Transdermal administration of melatonin. | |
DE3769707D1 (de) | Therapeutisches system mit geregelter wirkstoffabgabe. | |
ITMI921556A0 (it) | Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani | |
DE69309698D1 (de) | Hautbehandlung mit adhäsionsverstärkenden eigenschaften | |
IT8647625A0 (it) | Preparati farmaceutici con efficacia analgesica, nonche' loro produzione ed impiego | |
DE3875866D1 (de) | Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie. | |
DE68909501D1 (de) | Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien. | |
KR950702112A (ko) | 내장 진통 및 편두통의 치료 약물(Medicaments for the treatment of visceral pain and migraine) | |
FI973185A (fi) | Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon | |
ITMI911101A0 (it) | Farmaco attivo nelle malattie autoimmunitarie | |
FR2735132B1 (fr) | Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant | |
ITMI921612A0 (it) | Farmaco sintetizzato analogo della melatonina particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani | |
DE69306768D1 (de) | Medizinischer oder veterinaerer injektionsapparat | |
KR950700737A (ko) | 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness) | |
KR900009029A (ko) | 가축병 치료용 약물을 투여하는 장치 | |
NO960545D0 (no) | Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin | |
NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
DK554887D0 (da) | Terapeutisk middel samt dets anvendelse | |
NO941319L (no) | System for forbedret topisk levering av medikamenter med öket hudpenetrering | |
IT1190194B (it) | Combinazione di analgesico centrale ed adenina per il trattamento analgesico del corpo umano o animale e composizione farmaceutica che la contiene | |
ITFI920241A0 (it) | Impiego della melatonina nella terapia della sclerosi sistematica, della sarcoidosi ed altro |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970624 |